China Pharma HoldingSTU:XQJ 26 EV-to-FCF is 305.47 as of Jul. 11, 2026, which is 2790% above its 10-year median of 10.57. GuruFocus rates STU:XQJ with a GF Score™ of 26/100 and a GF Value™ of €10.05. The stock has 3 warning signs investors should review. Among 562 Drug Manufacturers companies, China Pharma Holding ranks worse than 95.37% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, China Pharma Holding's Enterprise Value is €23.52 Mil.
China Pharma Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €0.08 Mil. Therefore, China Pharma Holding's EV-to-FCF for today is 305.47.
The historical rank and industry rank for China Pharma Holding's EV-to-FCF or its related term are showing as below:
STU:XQJ'
s EV-to-FCF Range Over the Past 10 Years
Min: -124.77 Med: 10.57 Max: 2387.68
Current: 340.57
During the past 13 years, the highest EV-to-FCF of China Pharma Holding was 2387.68. The lowest was -124.77. And the median was 10.57.
STU:XQJ's EV-to-FCF is ranked worse than 95.37% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.765
vs STU:XQJ: 340.57
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Pharma Holding (STU:XQJ) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Pharma Holding's PE Ratio (TTM) for today is calculated as:
China Pharma Holding's share price for today is €26.80.
China Pharma Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.386.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Pharma Holding EV-to-FCF Related Terms
China Pharma Holding EV-to-FCF Historical Data
* Premium members only.
The historical data trend for China Pharma Holding's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's EV-to-FCF falls into.
China Pharma Holding's current Enterprise Value is €23.52 Mil.
China Pharma Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding (STU:XQJ) has a EV-to-FCF of 305.47 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Pharma Holding and its competitors. This is 2790% above median its historical median of 10.57. According to the industry distribution chart, China Pharma Holding ranks #536 out of 562 companies in the Drug Manufacturers industry, placing it in the top 95.4%.
Is China Pharma Holding's EV-to-FCF too high?
China Pharma Holding's current EV-to-FCF of 305.47 is 2790% above median its 10-year median of 10.57. The Drug Manufacturers industry median EV-to-FCF is 20.77. China Pharma Holding's value of 305.47 is 1371.1% above this industry median. Based on the distribution chart, China Pharma Holding ranks #536 out of 562 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's EV-to-FCF compare to TXMD and RMTI?
According to the Drug Manufacturers industry distribution chart, China Pharma Holding ranks #536 out of 562 companies for EV-to-FCF. This places China Pharma Holding in the lower half of its industry. The industry median EV-to-FCF is 20.77. China Pharma Holding's value of 305.47 is 1371.1% above this benchmark. While the company's 10-year median is 10.57 vs. the industry median of 20.77, China Pharma Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.77, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Pharma Holding's current EV-to-FCF of 305.47 is 1371.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Pharma Holding and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Pharma Holding's current EV-to-FCF is 305.47, which is 2790% above median its own 10-year median of 10.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current EV-to-FCF of 305.47. The stock's GF Value™ is €10.05, compared to a current price of €26.80 — trading 166.7% above its estimated fair value. The current EV-to-FCF is 305.47, which is 2790% above median its 10-year median of 10.57 and 1371.1% above the Drug Manufacturers industry median of 20.77. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current EV-to-FCF is 305.47 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Pharma Holding (STU:XQJ) Overvalued in 2026?
Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued.
The current stock price of €26.80 is trading 166.7% above its estimated GF Value™ of €10.05.
Key valuation signals for STU:XQJ:
EV-to-FCF: 305.47 (2790% above median its 10-year median of 10.57)
GF Value™: €10.05 vs. price of €26.80 (166.7% above fair value)
Industry Position: 1371.1% above the Drug Manufacturers median (#536 of 562)
No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score
Get the complete analysis for STU:XQJ
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:XQJ has been successfully added to your 
